Search results

Order by most recent / most popular / relevance

Results: 1-10 of 231

Prohibition not granted as non-infringement allegation held justified

Borden Ladner Gervais LLP
-
Canada
-
July 18 2012

The Court heard this application and the next application consecutively and issued decisions on the same day, however, indicated that each was considered separately

Intellectual property weekly abstracts bulletin

Borden Ladner Gervais LLP
-
Canada, USA
-
May 22 2013

The Supreme Court has dismissed Eli Lilly of Canada Inc.’s leave on the issue, as summarized by the Court, as to whether the creation by the Federal

Teva Canada Innovation v. Attorney General of Canada

Borden Ladner Gervais LLP
-
Canada
-
May 8 2013

The Patented Medicine Prices Review Board (the PMPRB) ordered Teva to pay the Crown approximately $2.4 million for selling its product at an

Patent ownership on the world stage

Borden Ladner Gervais LLP
-
Australia, Canada
-
September 27 2010

Prospective patentees of inventions that involve academic inventors would do well to revisit their employment contracts, collaborative agreements and internal procedures in view of the September 3, 2009 decision of the Full Court of the Federal Court of Australia in University of Western Australia v. Gray

Application for reissue denied

Borden Ladner Gervais LLP
-
Canada
-
May 1 2013

The Commissioner concurred with the findings of the Reissue Board and held that the patent did not meet the requirements under subsection 47(1) of the

Compound patent found valid in face of allegations of lack of utilitysound prediction and insufficiency

Borden Ladner Gervais LLP
-
Canada
-
February 27 2013

Apotex and Novopharm started actions to impeach Novartis’ patent covering the compound imatinib, sold under the brand name GLEEVEC. They then sent

Only authorized correspondent can pay maintenance fees for application

Borden Ladner Gervais LLP
-
Canada
-
November 14 2011

The Judge found that the acceptance of maintenance fees paid within the grace period by someone other than the authorized correspondent reinstated a lapsed patent application, but the subsequent reimbursement of those fees nullified the reinstatement

Patent application rejected again for obviousness

Borden Ladner Gervais LLP
-
Canada
-
May 28 2012

The Commissioner had previously refused the patent application on the basis of obviousness

Commissioner of Patents reverses examiner’s refusal to allow patent on basis of sound prediction and desired result arguments

Borden Ladner Gervais LLP
-
Canada
-
May 1 2013

The Application was rejected by the Examiner under section 2 of the Patent Act for containing claims for which the utility could not soundly be

NOC proceeding dismissed on the basis of overbreadth and a lack of sound prediction

Borden Ladner Gervais LLP
-
Canada
-
February 13 2013

In this case, one claim of a patent was at issue in the proceeding. The claim related to the use of pregabalin or its racemate to treat pain. The

next >

Search results

Prohibition not granted as non-infringement allegation held justified

Intellectual property weekly abstracts bulletin

Teva Canada Innovation v. Attorney General of Canada

Patent ownership on the world stage

Application for reissue denied

Compound patent found valid in face of allegations of lack of utilitysound prediction and insufficiency

Only authorized correspondent can pay maintenance fees for application

Patent application rejected again for obviousness

Commissioner of Patents reverses examiner’s refusal to allow patent on basis of sound prediction and desired result arguments

NOC proceeding dismissed on the basis of overbreadth and a lack of sound prediction

Current Search

Suggested Facets

Author

Jurisdiction

Workarea